⌘K
Loading ticker…
As of 2026-08-24, Cytek Biosciences, Inc. Common Stock (CTKB) has a 3-month relative strength percentile of 68 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.3%, relative volume 1.13×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
CTKB is held by 25 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $3M notional. Top 3 carry $6M.
Held by 57 ETFs · $101M across latest filings · largest weight 0.26% (SQLV).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $3M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | — |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.03% | $2M | — |
| VHTVanguard Health Care ETF | 0.01% | $1M | — |
| AVSC | 0.04% | $1M | — |
| GSSC | 0.05% | $538K | −0.04 pp |
| VTWV | 0.03% | $392K | — |
| VIOGVanguard S&P Small-Cap 600 Growth ETF | 0.04% | $356K | — |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.02% | $354K | — |
| PSCH | 0.25% | $323K | −0.05 pp |
Showing 10 of 25 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CTKB Jan avg: -5.21% median: -9.10% win: 25% σ: 17.70% n: 4 2022-04-12 → 2026-07-31 | CTKB Feb avg: -8.94% median: -11.61% win: 25% σ: 7.48% n: 4 2022-04-12 → 2026-07-31 | CTKB Mar avg: -9.20% median: -10.73% win: 0% σ: 4.60% n: 4 2022-04-12 → 2026-07-31 | CTKB Apr avg: 0.67% median: -7.48% win: 40% σ: 14.71% n: 5 2022-04-12 → 2026-07-31 | CTKB May avg: -13.80% median: -8.11% win: 20% σ: 14.37% n: 5 2022-04-12 → 2026-07-31 | CTKB Jun avg: 9.49% median: 9.35% win: 80% σ: 8.64% n: 5 2022-04-12 → 2026-07-31 | CTKB Jul avg: 9.12% median: 5.88% win: 80% σ: 10.58% n: 5 2022-04-12 → 2026-07-31 | CTKB Aug avg: -5.91% median: -11.72% win: 25% σ: 14.21% n: 4 2022-04-12 → 2026-07-31 (current) | CTKB Sep avg: -5.17% median: -9.83% win: 25% σ: 23.17% n: 4 2022-04-12 → 2026-07-31 | CTKB Oct avg: -4.16% median: -2.65% win: 50% σ: 16.25% n: 4 2022-04-12 → 2026-07-31 | CTKB Nov avg: 31.21% median: 38.46% win: 75% σ: 34.82% n: 4 2022-04-12 → 2026-07-31 | CTKB Dec avg: -0.15% median: -5.62% win: 25% σ: 22.60% n: 4 2022-04-12 → 2026-07-31 |